This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2020-2026.
Company Filing History:
Years Active: 2020-2026
Title: The Innovations of Patrick Bhola
Introduction
Patrick Bhola is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of cancer research, particularly through his innovative patent work. With a total of 3 patents, Bhola has developed technologies that enhance our understanding of cell sensitivity to various agents.
Latest Patents
One of Patrick Bhola's latest patents is titled "High throughput BH3 profiling: a rapid and scalable technology to BH3 profile on low numbers of cells." This invention provides methods for predicting cell sensitivity to a test agent. In some embodiments, the cells are cultured in a culture medium containing serum. This technology is crucial for advancing cancer treatment by allowing researchers to assess how different cells respond to potential therapies.
Career Highlights
Patrick Bhola is affiliated with the Dana-Farber Cancer Institute Inc., where he continues to push the boundaries of cancer research. His work focuses on developing scalable technologies that can be applied in clinical settings, ultimately aiming to improve patient outcomes.
Collaborations
Throughout his career, Bhola has collaborated with notable colleagues, including Anthony Letai and Jeremy Ryan. These partnerships have fostered a collaborative environment that enhances the research and development of innovative cancer therapies.
Conclusion
In summary, Patrick Bhola is a prominent inventor whose work in cancer research has led to significant advancements in understanding cell sensitivity. His patents and collaborations reflect his commitment to improving cancer treatment methodologies.